High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD.

BACKGROUND Gastroesophageal reflux disease (GERD) is common in a variety of chronic respiratory diseases, but little is known about GERD in the setting of COPD. The aims of this study were to determine the prevalence, presentation, and predictors of GERD based on proximal and distal esophageal pH monitoring in patients with severe COPD. METHODS Forty-one COPD patients with a mean FEV1 of 24% of predicted underwent dual-probe 24-h esophageal pH monitoring, and 1 patient underwent esophagogastroduodenoscopy. RESULTS The prevalence of GERD was 57%. Elevated distal and proximal reflux were present in 41% and 46% of patients undergoing esophageal pH studies, respectively. Fifteen percent of these patients had abnormal proximal reflux despite having normal distal probe results. Most patients with GERD were not receiving acid blockers at the time of their referral, and only one third reported heartburn and/or acid regurgitation during the pH study. Only higher body mass index was predictive of reflux on regression analysis (odds ratio, 1.2; 95% confidence interval, 1.0 to 1.5; p = 0.05). CONCLUSIONS GERD is common in advanced COPD. Patients are often asymptomatic and have a relatively high prevalence of isolated abnormal proximal reflux. Dual-probe monitoring is therefore well suited for detecting GERD in patients with advanced COPD.

[1]  S. Field,et al.  Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. , 2006, American journal of respiratory and critical care medicine.

[2]  G. Raghu,et al.  Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. , 2006, Chest.

[3]  D. Sugarbaker,et al.  Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. , 2006, The Journal of thoracic and cardiovascular surgery.

[4]  G. Raghu,et al.  High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis , 2006, European Respiratory Journal.

[5]  G. Darling,et al.  Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. , 2005, The Annals of thoracic surgery.

[6]  G. Snell,et al.  Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  M. Littner,et al.  Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. , 2005, Chest.

[8]  J. Dent,et al.  Epidemiology of gastro-oesophageal reflux disease: a systematic review , 2005, Gut.

[9]  R. Sampliner,et al.  Barrett's esophagus and other mucosal evidence of reflux in asymptomatic subjects with abnormal 24-hour esophageal pH monitoring , 1994, Digestive Diseases and Sciences.

[10]  J. Richter,et al.  Normal 24-Hr ambulatory esophageal pH values , 1992, Digestive Diseases and Sciences.

[11]  June A. Castell,et al.  Esophageal manometry in 95 healthy adult volunteers , 1987, Digestive Diseases and Sciences.

[12]  J. Tack,et al.  Characteristics and Clinical Relevance of Proximal Esophageal pH Monitoring , 2004, American Journal of Gastroenterology.

[13]  Jeff W. Allen,et al.  Proximal Sensor Data from Routine Dual-Sensor Esophageal pH Monitoring Is Often Inaccurate , 2004, Digestive Diseases and Sciences.

[14]  B. Celli,et al.  Increased gastro-oesophageal reflux disease in patients with severe COPD , 2004, European Respiratory Journal.

[15]  J. Hunter,et al.  Dual-Channel Ambulatory Esophageal pH Monitoring (A Useful Diagnostic Tool?) , 1997, Digestive Diseases and Sciences.

[16]  J. Pandolfino,et al.  Ambulatory Esophageal pH Monitoring Using a Wireless System , 2003, American Journal of Gastroenterology.

[17]  M. Steele,et al.  Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. , 2003, The Journal of thoracic and cardiovascular surgery.

[18]  M. Crowell,et al.  The Effects of an Inhaled β2-Adrenergic Agonist on Lower Esophageal Function: A Dose-Response Study , 2001 .

[19]  D. Kamp,et al.  Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. , 2001, Chest.

[20]  J. Richter,et al.  The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. , 2000, American journal of respiratory and critical care medicine.

[21]  S. Elsenbruch,et al.  Proximal migration of esophageal acid perfusions during waking and sleep , 2000, American Journal of Gastroenterology.

[22]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[23]  J. Richter,et al.  Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. , 1996, The American journal of medicine.

[24]  B. Weusten,et al.  Spatiotemporal characteristics of physiological gastroesophageal reflux. , 1994, The American journal of physiology.

[25]  W. Orr,et al.  Esophageal function and gastroesophageal reflux during sleep and waking in patients with chronic obstructive pulmonary disease. , 1992, Chest.

[26]  S. O'connell,et al.  Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. , 1990, Gastroenterology.

[27]  D. Coumaros,et al.  Gastroesophageal reflux in patients with asthma and chronic bronchitis. , 1987, The American review of respiratory disease.